Dr Giulia Reggiani – HELIOS YRI Discussion Club: Long-term effects of disease-modifying and disease curative therapies on organ damage in sickle cell disease
Our monthly discussion club is back!
We invite all HELIOS members to our upcoming presentation by Dr Giulia Reggiani. The topic of discussion will be “Long-term effects of disease-modifying and disease curative therapies on organ damage in sickle cell disease.” The event will held online through the Microsoft Teams platform on the 4th of June at 2 pm CET.
Organiser: HELIOS Young Researchers and Innovators Monthly Discussion Club are organized by HELIOS Young and Innovators Coordinator Dr. Eleni Gavriilaki
The club provides a platform for networking and exchanging insights on hemoglobinopathies research projects and innovative concepts, specifically within the Young Researchers and Innovators Group associated with the HELIOS Cost Action. If you wish to showcase your work and engage in our discussion session, please reach out to us by sending an email to Young Researchers and Innovators Coordinator Dr Eleni Gavriilaki at [email protected] or to HELIOS Grant Manager Dr Sotiroula Chatzimatthaiou at [email protected].
If you wish to become part of the HELIOS COST Action, please apply through the following link.
Additional Details
Speaker -
Speaker.
Organizer
Dr Gavriilaki has trained and specialized at the Hematology Department – BMT Unit of G Papanicolaou Hospital. Her clinical and translational research focused on complement-related diseases, with a special interest in thrombotic microangiopathies. Her work led to multiple national and international presentations, esteemed awards and grants, as well as publications in renowned journals. She now serves as an Assistant Professor of Hematology. She is an active advocate of early career scientists and physicians, with her participation in EHA, ASH and the current Cost Action HELIOS.